Patent Grant
11470860
This application is a U.S. National Stage Application under 35 U.S.C. § 371 of International Patent Application No. PCT/GB2017/000028, filed Mar. 1, 2017, which claims the benefit of priority under 35 U.S.C. Section 119(e) of British Patent Application number 1603596.6 filed Mar. 2, 2016, both of which are incorporated by reference in their entireties. The International Application was published on Sep. 8, 2017, as International Publication No. WO 2017/149266 A1.
This invention relates to specific glycolipids for providing improved animal feeds.
It is known to supplement animal feeds with different additives to improve animal performance, for example adding specific phospholipids to the animal feed as described in WO 00/36929 or WO 94/22324. New feed additives are desired to further improve performance, such as growth of the animal. It is preferable for such feed additives to be naturally-occurring.
It is an aim of the present invention to provide novel animal feed additives that promote animal performance, particularly but not exclusively, animal growth.
Accordingly, a first aspect of the present invention provides an animal feed suitable for feeding mammals, birds and fish, the animal feed comprising at least one sophorolipid having the following general formulas (1) or (2):
wherein
R represents hydrogen or an acyl group having 1 to 4 carbon atoms;
R1 represents hydrogen or an acetyl group;
R2 represents hydrogen or alkyl group having 1 to 9 carbon atoms;
R3 represents a saturated or unsaturated hydrocarbon group containing 6 to 18 carbon atoms; and
X represents a functional group selected from the group consisting of an aldehyde, a hydroxyl, a carboxylic acid, an acyl group, an amide and a monosaccharide having a glycosidic linkage.
R is preferably hydrogen. R2 is preferably a hydrogen or methyl group. R3 is preferably a hydrocarbon group containing 16 to 18 carbon atoms, more preferably 16 carbon atoms. Normally, R3 will have one site that is unsaturated (C═C bond).
Preferably, the sophorolipids in the animal feed comprise at least 50% by weight sophorolipids having the general formula (2).
Preferably, the sophorolipid comprises at least 0.05 wt. % to 0.1 wt. % of the feed. For example, preferably 0.05 to 0.5 g of sophorolipid is included in 1 kg of feed (50 to 500 g per tonne of feed).
The sophorolipid may be added to the animal feed by itself. In a preferred embodiment, the sophorolipid is combined with a lysolecithin.
A second aspect of the present invention provides an ingredient, premix or supplement for an animal feed suitable for feeding mammals, birds and fish, comprising at least one sophorolipid the following general formulas (1) or (2):
wherein
R represents hydrogen or an acyl group having 1 to 4 carbon atoms;
R1 represents hydrogen or an acetyl group;
R2 represents hydrogen or alkyl group having 1 to 9 carbon atoms;
R3 represents a saturated or unsaturated hydrocarbon group containing 6 to 18 carbon atoms; and
X represents a functional group selected from the group consisting of an aldehyde, a hydroxyl, a carboxylic acid, an acyl group, an amide and a monosaccharide having a glycosidic linkage;
and wherein the dosage of said sophorolipid in said animal feed is 0.01 wt. % or higher, based on the total weight of said ingredient, premix or supplement, wherein said ingredient, premix or supplement further comprises at least one of vitamins, trace elements, minerals and organic acids.
Other surface active ingredients and/or emulsifiers may be included in the ingredient, premix or supplement according to the second aspect of the present invention.
Preferably, the second aspect of the present invention provides an ingredient, premix or supplement for an animal feed suitable for feeding mammals, birds and fish, comprising or consisting essentially of at least one sophorolipid having the following general formulas (1) or (2) above and at least one lysolecithin. More preferably, the supplement is at least 50% by weight lysolecithin, more preferably at least 75% by weight. The lysolecithin may comprise a blend of lecithins and lysolecithins, such as that sold under the proprietary name Lipidol.
A third aspect of the present invention provides a method for increasing the feed conversion rate in an animal comprising feeding a mammal, bird or fish with the animal feed according to the first aspect of the invention or with the ingredient, premix or supplement according to the second aspect of the invention.
In the context of this disclosure, the feed conversion rate (FCR) is a ratio or rate for measuring the efficiency with which animals, such as livestock, convert animal feed into a desired output. FCR is the mass of the input divided by the output (for example, kilos of feed per kilo of meat or milk). Animals with low FCR values are considered efficient users of feed.
A fourth aspect of the present invention relates to the use of a sophorolipid in the preparation of a feed supplement for the improvement of a feed conversion rate in an animal.
More preferably, at least one sophorolipid has the following general formulas (1) or (2):
wherein
R1 represents hydrogen or an acetyl group;
R2 represents hydrogen or alkyl group having 1 to 9 carbon atoms; and
R3 represents a saturated or unsaturated hydrocarbon group containing 15 to 18 carbon atoms.
More preferably still, the fourth aspect of the present invention relates to the use of a sophorolipid and lysolecithin mix in the preparation of a feed supplement for the improvement of a feed conversion rate in an animal.
The animal feed may be suitable for any type of animal, such as mammals, birds, fish, reptiles, amphibians but preferably is a bird feed additive, especially poultry.
Embodiments of the invention shall now be described, by way of example only, with reference to the accompanying drawings in which:
The present invention relates to the use of sophorolipids as an animal feed supplement. A sophorolipid is a surface-active glycolipid that can be synthesized by non-pathogenic yeasts, the main one being Candida bombicola using raw ingredients such as vegetable oils. Sophorolipids reduce surface tension and therefore are used as surfactants in detergents but also possess a number of useful biological activities including antimicrobial, virucidal, anticancer and inmuno-modulatory properties. Sophorolipids have previously been used for the treatment of skin and hair (see, for example, WO 95/34282 and U.S. Pat. No. 5,981,497).
The production of sophorolipids is well documented in the art, see for example, “Production of sophorolipids by the yeast Candida bombicola using simple and low cost fermentative media” Davery and Pakshirajan, Food Research International 42 (2009) 499-504.
Sophorolipids are comprised of a sugar head sophorose, an unusual β-(1,2) disaccharide consisting of two glucose molecules, covalently linked to a long chain hydroxylated fatty acid having a fatty acid chain length of 16-18 carbon atoms. Two types of esterification can occur which have a big effect on the molecule's behaviour, namely (i) acetylation and (ii) lactonization. Acetylation takes place at the C6′ and C6″ positions of the sophorose resulting in a mixture of non-, mono- and di-acetylated molecules. Acidic sophorolipids are not readily soluble in aqueous medium at acidic pH but become soluble at higher pH. However, these sophorolipids show instability at pH higher than 7.0. Lactonization converts the open-chain or acid sophorolipid to a closed-chain sophorolipid (lactonic form), specific for position C4″, see below. The lactonised sophorolipids are stable across a wider pH range.
(i) Acidic Sophorolipid:
(ii) Lactonic Sophorolipid.
The present invention has surprisingly found that both acidic and lactonic sophorolipids may be added to animal feedstuffs to improve the performance of the animal. This is surprising because sophorolipids, especially the acidic form, would be expected to be destroyed by the stomach acid in the stomach of the animal thereby resulting in minimal, if any, effect on the bodyweight of the animal. Previously, oral administration of sophrolipids has not been considered due to it being readily hydrolyzed in the stomach as well as intestine. Natural sophorolipids containing around 50% of the acidic and lactonic forms may be used as the feed additive. The lactonic sophorolipids are preferred.
Birds were fed identical diets over a period of 35 days but the diet of the treated birds was supplemented with 125 g of a sophorolipid/lysolecithin mix per ton of feed that has been cultivated from C. bombicola. 50% of the sophorolipid was in the lactonic form, thus the feed contained 62.5 g per ton of feed. The mix was 75% lysolecithins and 25% sophorolipids at a range of inclusion levels up to 250 ppm. The control and treated groups consisted each of replicates of 10 birds (total of 100 birds for each group). The three phases of the trial were BOOSTER (Day 1-14), STARTER (Day 15-28) and FINISHER (Day 35).
The data obtained for the control group and treated group are provided in the tables below:
I. Control Group.
II Treated Group
These results are shown graphically in
The overall conversion ratio or rate (FCR) was shown to be lower in the treated group than the control group (see
Modifications to the sophorolipid molecules have also been carried out in the art and such modified sophorolipids are also suitable for use in the animal feed supplement according to the invention. Examples of such modified sophorolipids are given below (i to vii). Their methods of production are described in articles, such as “Enzymatic Synthesis of a Galactopyranose Sophorolipid Fatty Acid Ester” Nunez, Foglia and Ashby, Biotechnology Letters (2003) 25: 1291-1297 and “Enzyme-catalyzed regioselective transesterification of peracylated sophorolipids” Carr and Bisht, Tetrahedron 59 (2003) 7713-7724.
Another trial was carried out in a similar manner to Example 1 above with control and treated groups of birds with the birds being fed identical experimental diets over a period of 35 days but the diet of the treated birds was supplemented with a pure sophorolipid (SPL) supplement at a range of inclusion levels up to 250 ppm. The sophorolipid was provided as a powder with 50% sophorolipids liquid with 50% silicon dioxide.
The composition of the Experimental diet is provided below:
Results: Effect of Pure SPLs on Growth Performance in Broilers.
Table 1 below provides the average daily gain (ADG) (g) for the control and treated birds.
Table 2 below provides the feed intake (FI) (g) for the control and treated birds.
Table 3 below provides the feed efficiency (FE) (g) for the control and treated birds.
Examples 1 and 2 above demonstrate that sophorolipids, both alone and in combination with lysolecithin, enhance the feed conversion rate of animals. Example 2 shows that the incorporation of 25-250 ppm pure sophorolipid into an animal feed consistently improves the FCR of the animal compared with the control birds, particularly during the first 8-21 days of the trial, as illustrated in the Table 4 below and shown graphically in
However, the incorporation of a lysolecithin blend and sophorolipid mix (250 ppm) into the animal feed provided better improvement in the FCR relative to the control birds over the entire 35 day trial, as illustrated in Table 5 below and shown graphically in
Thus, this indicates that a lysolecithin/sophorolipid mix provides an improved animal feed supplement. While the inventor does not wish to be bound to the theory, it is believed that the improvement may be due to the different HLB values of the lipids. The HLB value provides an indication of the size of the hydrophilic portion of molecule relative to the molecular mass of the entire molecule. The HLB value of sophorolipids is higher than lysolecithins, thus the overall HLB value of the combination will be pushed upward. As a result, a mixture should improve the emulsification of oil-in water mixtures, as found in the gut of an animal.
Lecithins, particularly lysolecithins or hydrolysed lecithins may therefore be combined with one or more sophorolipids to provide an animal feed supplement according to the present invention. Various types of lecithin or lysolecithin may be used, including blends thereof. Lecithin is a generic term which applies to any complex mixture of lipids containing phosphoric acid, choline, fatty acids, glycerol, glycolipids, triglycerides and phospholipids, including phosphatidycholine, phosphatidylethanolamine, phosphatidylinositol. More preferably, the lecithin blend includes at least one hydrolysed phospholipid wherein one of the fatty acid chains of the phospholipid is hydrolysed and substituted with hydrogen to yield a lysophospholipid.
A preferred lysolecithin for use in the present invention is that sold under the proprietary name of Lipidol, consisting of lecithins and lysolecithins having the following phospholipid profile:
Lysophosphatidylethanolamine
| Number | Date | Country | Kind |
|---|---|---|---|
| 1603596 | Mar 2016 | GB | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/GB2017/000028 | 3/1/2017 | WO |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2017/149266 | 9/8/2017 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 20040023922 | Porter | Feb 2004 | A1 |
| 20040171512 | Furuta | Sep 2004 | A1 |
| 20110177194 | Van Dyck et al. | Jul 2011 | A1 |
| 20150112049 | Hirata | Apr 2015 | A1 |
| Number | Date | Country |
|---|---|---|
| 102696880 | Oct 2012 | CN |
| 102696895 | Oct 2012 | CN |
| 3117838 | Jan 2017 | EP |
| 3012725 | May 2015 | FR |
| 2010220516 | Oct 2010 | JP |
| 2012232963 | Nov 2012 | JP |
| 100572574 | Apr 2006 | KR |
| 0036929 | Jun 2000 | WO |
| 2010050413 | May 2010 | WO |
| 2014193856 | Dec 2014 | WO |
| 2015137357 | Sep 2015 | WO |
| Entry |
|---|
| Pichot et al. Journal of Colloid and Interface Science 329 (2009) 284-2910. (Year: 2009). |
| International Search Report and Written Opinion in corresponding International Patent Application No. PCT/GB2017/000028, dated Jun. 21, 2017. 11 pages. |
| International Preliminary Report on Patentability in corresponding International Patent Application No. PCT/GB2017/000028, dated Sep. 4, 2018. 8 pages. |
| Li et al. “Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on polymethoxyflavone crystallization.” Food hydrocolloids 27.2 (2012): 517-528. |
| Search Report in corresponding British Patent Application No. GB 1603596.6 dated Dec. 21, 2016. 1 page. |
| Baccile et al. “Unusual, pH-induced, self-assembly of sophorolipid biosurfactants.” ACS nano 6.6 (2012): 4763-4776. |
| Van Bogaert, Inge N A et al. “Microbial production and application of sophorolipids.” Applied microbiology and biotechnology vol. 76,1 (2007): 23-34. doi:10.1007/s00253-007-0988-7. |
| Zhou, Shuiqin et al. “Supramolecular assemblies of a naturally derived sophorolipid.” Langmuir: the ACS journal of surfaces and colloids vol. 20,19 (2004): 7926-32. doi:10.1021/la048590s. |
| Number | Date | Country | |
|---|---|---|---|
| 20190037885 A1 | Feb 2019 | US |
